Table 2.

Overview of the dependent variables in the diminishing-utility task, as a function of treatment and sex (SD in parentheses).

	Placebo		Citalopram		Reboxetine
	Men	Women	Men	Women	Men	Women
Mean epoch length (trials)	10.3 (2.3)	12.1 (4.3)	9.9 (2.5)	10.9 (4.1)	11.0 (3.8)	11.0 (2.3)
Number of escapes	12.8 (3.1)	11.5 (4.0)	13.4 (3.7)	12.9 (5.1)	13.3 (5.9)	11.8 (4.7)
Total score	1694 (380)	1749 (418)	1496 (537)	1674 (404)	1904 (353)	1356 (391)
Total number of trials	136 (3)	136 (3)	135 (3)	136 (3)	138 (3)	132 (3)